SNIPR Biome
Business Services · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Lersø Parkallé 44, Copenhagen, Capital R...Website
www.sniprbiome.comRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About SNIPR Biome
SNIPR Biome is a Danish clinical-stage biotech company pioneering the development of CRISPR-medicine. The company is pioneering a novel use of CRISPR-Cas technology to better treat and prevent human diseases through precision killing of bacteria or gene modification. SNIPR Biome was the first company to orally dose humans with a CRISPR therapeutic and the first company to have been granted US and European patents for the use of CRISPR for targeting microbiomes.Explore more
SNIPR Biome Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SNIPR Biome your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if SNIPR Biome had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when SNIPR Biome launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on SNIPR Biome recently announced quarterly report
SNIPR Biome, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if SNIPR Biome is spiking on competitors!
Funding: Get notified immidiatlly once SNIPR Biome has new funding data
Congratulate Masked Content for being promoted to Masked Content at SNIPR Biome
Check if SNIPR Biome has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined SNIPR Biome as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
SNIPR Biome is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SNIPR Biome is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SNIPR Biome.
SNIPR Biome financials insights
Gather financial insights about SNIPR Biome, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$50M
2025
Series B
$40.8M
SNIPR Biome Tech Stack
A closer look at the technologies used by SNIPR Biome
Most Recent Scoops
Funding
Funding
Project
Product Development, Research & Development, Product Management, Intellectual Property, Legal Affairs, Medical Research
Left Company
Executive Move
New Hire
Executive Move
New Hire
Executive Move
SNIPR Biome News & Media
SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance
SNIPR Biome today announced the close of a EUR 35 million Series B financing round addressing antimicrobial resistance and infectious disease.SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer
SNIPR BIOME today announced that the first patient has been dosed in its Phase 1b study of SNIPR001 in patients with hematological cancer.SNIPR Biome Strengthens IP Portfolio with Patent Granted for a Novel CRISPR-Cas System
Grant of a patent on February 26th 2025 by the European Patent Office protecting the newly-discovered and characterised CRISPR-CasS system.SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteric Dysfunction (EED) in pregnant women
SNIPR BIOME receives funding from the Bill & Melinda Gates Foundation to accelerate the development of SNIPR Biome's microbial gene therapy platform.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SNIPR Biome
Sign Up For FreeTo access detailed company insights
SNIPR Biome is a Danish clinical-stage biotech company pioneering the development of CRISPR-medicine. The company is pioneering a novel use of CRISPR-Cas technology to better treat and prevent human diseases through precision killing of bacteria or gene modification. SNIPR Biome was the first company to orally dose humans with a CRISPR therapeutic... Read More
